Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹152.34
Market cap: ₹2,388 Cr
Revenue (annual): ₹2,932 Cr
Net profit (annual): ₹97.45 Cr
P/E (TTM): 147.8×Sector 47.4×
Promoter holding: 59.32%+0.00% QoQ
FII holding: 6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 15 Other Announcement 4 Management Change 4 Annual General Meeting 4 Financial Results 3 Earnings Call 3 Board Meeting Date 2 Production Started 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

7 Aug 2026 18:06 IST BSE

Board Meeting Date

Dishman Carbogen Amcis Board Meeting Date

Dishman Carbogen Amcis Ltd will hold a board meeting on August 12, 2026, to consider a proposal for raising funds via non-convertible debentures.

Read the filing ↗

14 May 2026 20:34 IST BSE

Board Meeting Date

Dishman Carbogen Amcis Board Meeting Date

Dishman Carbogen Amcis scheduled a board meeting for May 19, 2026. Key agenda items include approving annual results and a ₹1282.50 Crore promoter-group loan.

Value: ₹1,282 Cr

Read the filing ↗